DISHMAN CARBOGEN AMCIS Financial Statement Analysis
|
||
|
The Revenues of DISHMAN CARBOGEN AMCIS have increased by 12.72% YoY .
The Earnings Per Share (EPS) of DISHMAN CARBOGEN AMCIS has decreased by Negative YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
DISHMAN CARBOGEN AMCIS Last 5 Annual Financial Results
[BOM: 540701|NSE : DCAL]
| Consolidated | Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 |
|---|---|---|---|---|---|
| Revenues | ₹2,413 Cr | ₹2,141 Cr | ₹1,912 Cr | ₹2,044 Cr | ₹2,059 Cr |
| Expenses | ₹2,081 Cr | ₹1,815 Cr | ₹1,638 Cr | ₹1,546 Cr | ₹1,507 Cr |
| Operating Profit (Excl OI) | ₹332 Cr | ₹326 Cr | ₹274 Cr | ₹498 Cr | ₹552 Cr |
| Other Income | ₹28 Cr | ₹49 Cr | ₹39 Cr | ₹44 Cr | ₹54 Cr |
| Interest | ₹86 Cr | ₹57 Cr | ₹48 Cr | ₹62 Cr | ₹57 Cr |
| Depreciation | ₹281 Cr | ₹308 Cr | ₹308 Cr | ₹283 Cr | ₹240 Cr |
| Profit Before Tax | ₹-55 Cr | ₹-4.25 Cr | ₹-65 Cr | ₹197 Cr | ₹309 Cr |
| Profit After Tax | ₹-30 Cr | ₹18 Cr | ₹-165 Cr | ₹159 Cr | ₹210 Cr |
| Consolidated Net Profit | ₹-30 Cr | ₹18 Cr | ₹-165 Cr | ₹159 Cr | ₹210 Cr |
| Earnings Per Share (Rs) | ₹-9.79 | ₹-1.90 | ₹1.15 | ₹-10.53 | ₹10.10 |
| PAT Margin (%) | -5.87 | -1.24 | 0.84 | -8.64 | 7.76 |
| ROE(%) | -2.68 | -0.52 | 0.32 | -2.89 | 2.86 |
| ROCE(%) | -0.03 | 0.43 | 0.76 | -0.26 | 3.93 |
| Total Debt/Equity(x) | 0.35 | 0.31 | 0.26 | 0.20 | 0.18 |
Key Financials |
||
| Market Cap | : | ₹ 3,376.7 Cr |
| Revenue (TTM) | : | ₹ 2,649.9 Cr |
| Net Profit(TTM) | : | ₹ -109.8 Cr |
| EPS (TTM) | : | ₹ -7.0 |
| P/E (TTM) | : | - |
| Industry Peers & Returns | 1W | 1M | 1Y |
| DISHMAN CARBOGEN AMCIS | 2.5% | -6.1% | -5.6% |
| SUN PHARMACEUTICAL INDUSTRIES | 3.1% | 3.1% | 17.5% |
| DIVIS LABORATORIES | 10.2% | 6.7% | 61.3% |
| CIPLA | 2.4% | 2.5% | 14% |
| TORRENT PHARMACEUTICALS | 2.1% | 2.9% | 31.4% |
| DR REDDYS LABORATORIES | 3.2% | 1.3% | -0.2% |
| MANKIND PHARMA | 0.8% | 15.9% | 9% |
| ZYDUS LIFESCIENCES | 5.8% | -4% | -5.9% |
| LUPIN | 8.7% | 1% | 35% |
DISHMAN CARBOGEN AMCIS Revenues
[BOM: 540701|NSE : DCAL]
| Y-o-Y | 12.72 % |
| 5 Yr CAGR | 4.05 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2024 | ₹2,413 Cr | 12.72 | |
| Mar2023 | ₹2,141 Cr | 11.96 | |
| Mar2022 | ₹1,912 Cr | -6.44 | |
| Mar2021 | ₹2,044 Cr | -0.73 | |
| Mar2020 | ₹2,059 Cr | - | |
DISHMAN CARBOGEN AMCIS Operating Profit
[BOM: 540701|NSE : DCAL]
| Y-o-Y | 2.01 % |
| 5 Yr CAGR | -11.92 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2024 | ₹332 Cr | 2.01 | |
| Mar2023 | ₹326 Cr | 18.76 | |
| Mar2022 | ₹274 Cr | -44.89 | |
| Mar2021 | ₹498 Cr | -9.85 | |
| Mar2020 | ₹552 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -9.47 % |
| 5 Yr CAGR | -15.34 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2024 | 13.77% | -9.47 | |
| Mar2023 | 15.21% | 6.07 | |
| Mar2022 | 14.34% | -41.11 | |
| Mar2021 | 24.35% | -9.18 | |
| Mar2020 | 26.81% | - | |
DISHMAN CARBOGEN AMCIS Profit After Tax
[BOM: 540701|NSE : DCAL]
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2024 | ₹-30 Cr | Negative | |
| Mar2023 | ₹18 Cr | Positive | |
| Mar2022 | ₹-165 Cr | Negative | |
| Mar2021 | ₹159 Cr | -24.64 | |
| Mar2020 | ₹210 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2024 | -5.87 % | Negative | |
| Mar2023 | -1.24 % | Negative | |
| Mar2022 | 0.84 % | Positive | |
| Mar2021 | -8.64 % | Negative | |
| Mar2020 | 7.76 % | - | |
DISHMAN CARBOGEN AMCIS Earnings Per Share (EPS)
[BOM: 540701|NSE : DCAL]
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2024 | ₹-9.79 | Negative | |
| Mar2023 | ₹-1.90 | Negative | |
| Mar2022 | ₹1.15 | Positive | |
| Mar2021 | ₹-11 | Negative | |
| Mar2020 | ₹10 | - | |
DISHMAN CARBOGEN AMCIS Return on Capital Employed (ROCE)
[BOM: 540701|NSE : DCAL]
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2024 | -0.03% | Negative | |
| Mar2023 | 0.43% | -43.42 | |
| Mar2022 | 0.76% | Positive | |
| Mar2021 | -0.26% | Negative | |
| Mar2020 | 3.93% | - | |
DISHMAN CARBOGEN AMCIS Share Price vs Sensex
| Current Share Price | : | ₹215.4 |
| Current MarketCap | : | ₹ 3,376.7 Cr |
| Updated EOD on | : | Apr 24,2025 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DISHMAN CARBOGEN AMCIS | 2.5% |
-6.1% |
-5.6% |
| SENSEX | 3.6% |
5.8% |
10.1% |
DISHMAN CARBOGEN AMCIS related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE ALLCAP | 6.4% | 8.9% | 7.5% |
| BSE MIDSMALLCAP | 4.7% | 9% | 8.4% |
| BSE HEALTHCARE | 3.9% | 4.7% | 24.2% |
| BSE SMALLCAP | 3.3% | 7.1% | 8.4% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY TOTAL MARKET | 3.6% | 6.3% | 9.2% |
| NIFTY MICROCAP 250 | 3.6% | 6.3% | 9.9% |
You may also like the below Video Courses
FAQ about DISHMAN CARBOGEN AMCIS Financials
How the annual revenues of DISHMAN CARBOGEN AMCIS have changed ?
The Revenues of DISHMAN CARBOGEN AMCIS have increased by 12.72% YoY .
How the Earnings per Share (EPS) of DISHMAN CARBOGEN AMCIS have changed?
The Earnings Per Share (EPS) of DISHMAN CARBOGEN AMCIS has decreased by Negative YoY .
Check out Intrinsic Value of Peers of DISHMAN CARBOGEN AMCIS
Compare Stock Analytics of Peers of DISHMAN CARBOGEN AMCIS
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
